Description
Aim: In vivo evaluation of microglia activation and neuroinflammation is considered a potential tool in the management of several neurological and psychiatric disorders. [11C]PK11195 has been widely used for this purpose in PET imaging. However, it possesses a low sensitivity and poor signal-to-noise ratio. For that reason, [11C]CB184 was evaluated as a potential more sensitive PET tracer, using a rat model of herpes encephalitis. Materials and methods: Male Wistar rats were intranasal inoculated with HSV-1 (HSE) or PBS (control). At either day 6 or 7 after inoculation, [11C]CB184 PET scans were acquired, followed by ex vivo biodistribution. Arterial blood sampling of [11C]CB184 and [11C]PK11195 scans was performed for pharmacokinetic modelling. Differences between control and HSE groups were explored using volumes of interest and voxel-based analysis. Results: The ex vivo uptake of [11C]CB184 in HSE rats, as compared with control, was significantly increased (pPeriode | 19-okt.-2014 |
---|---|
Evenementstitel | 28th Annual Congress of the European Association of Nuclear Medicine (EANM) |
Evenementstype | Conference |
Conferentienummer | 28 |
Locatie | Hamburg, GermanyToon op kaart |
Gerelateerde inhoud
-
Onderzoeksoutput
-
Evaluation of [C-11]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis
Onderzoeksoutput › Academic › peer review